Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
002675.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥12,533,855 | CN¥11,865,932 | CN¥10,857,137 | CN¥10,076,563 |
| - Cash | CN¥1,045,039 | CN¥742,712 | CN¥697,377 | CN¥755,972 |
| + Debt | CN¥1,282,614 | CN¥766,031 | CN¥727,445 | CN¥784,620 |
| Enterprise Value | CN¥12,771,429 | CN¥11,889,251 | CN¥10,887,205 | CN¥10,105,211 |
| Revenue | CN¥659,377 | CN¥696,784 | CN¥686,928 | CN¥706,505 |
| % Growth | -5.4% | 1.4% | -2.8% | – |
| Gross Profit | CN¥382,543 | CN¥330,511 | CN¥311,422 | CN¥362,763 |
| % Margin | 58% | 47.4% | 45.3% | 51.3% |
| EBITDA | CN¥155,403 | CN¥152,829 | CN¥90,961 | CN¥46,561 |
| % Margin | 23.6% | 21.9% | 13.2% | 6.6% |
| Net Income | CN¥60,463 | CN¥63,921 | CN¥24,732 | CN¥16,958 |
| % Margin | 9.2% | 9.2% | 3.6% | 2.4% |
| EPS Diluted | 0.073 | 0.078 | 0.03 | 0.021 |
| % Growth | -5.4% | 158.3% | 45.6% | – |
| Operating Cash Flow | CN¥74,527 | CN¥153,570 | CN¥114,036 | CN¥102,204 |
| Capital Expenditures | -CN¥39,719 | -CN¥88,576 | -CN¥73,832 | -CN¥83,052 |
| Free Cash Flow | CN¥34,807 | CN¥64,994 | CN¥40,205 | CN¥19,152 |